|Year : 2011 | Volume
| Issue : 6 | Page : 644-647
Antihyperlipidemic potential of Cedrus deodara extracts in monosodium glutamate induced obesity in neonatal rats
Sudhir Patil1, T Prakash1, D Kotresha2, N Rama Rao3, Naitik Pandy1
1 Department of Pharmacology, Acharya and B.M. Reddy College of Pharmacy, Bangalore-560 090, India
2 Department of Biochemistry, Indian Institute of Science, Bangalore- 560 012, Karnataka, India
3 Department of Pharmaceutical Chemistry, Chalapathi Institute of Pharmaceutical Science, Guntur-522 034, Andhra Pradesh, India
|Date of Submission||22-Feb-2011|
|Date of Decision||13-May-2011|
|Date of Acceptance||02-Sep-2011|
|Date of Web Publication||14-Nov-2011|
Department of Pharmacology, Acharya and B.M. Reddy College of Pharmacy, Bangalore-560 090
Objective : To study the antihyperlipidemic effect of Cedrus deodara (C. deodara) against monosodium glutamate (MSG) induced obesity in neonatal rats.
Materials and Methods : The studies were carried out on newborn neonatal rats and were injected intraperitoneally with 2 mg/g of MSG on the 2 nd and 4 th postnatal days and 4 mg/g on 6 th , 8 th and 10 th postnatal days. Ethanolic extract (EE) and acetone extract (AE) of C. deodara was administered in a dose of 100 and 200 mg/kg, p.o./day at the age of 65 days. On day 60 of treatment, body weight, locomotor activity, body temperature, and various biochemical parameters like serum glucose, total cholesterol, triglyceride, and organs weights were recorded.
Results : There was a significant reduction in body weight, organs and increased body temperature, locomotor activity after treatment with extracts. C. deodara decreased serum glucose, total cholesterol and triglyceride, low density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels and increased high density lipoprotein (HDL) significantly has compared to MSG-control rats.
Conclusion : C. deodara extracts exhibited antihyperlipidemic effect and it possesses anti-obesity properties in MSG induced obese rats.
Keywords: Antihyperlipidemic, Cedrus deodara, monosodium glutamate, neonatal, obesity
|How to cite this article:|
Patil S, Prakash T, Kotresha D, Rao N R, Pandy N. Antihyperlipidemic potential of Cedrus deodara extracts in monosodium glutamate induced obesity in neonatal rats. Indian J Pharmacol 2011;43:644-7
|How to cite this URL:|
Patil S, Prakash T, Kotresha D, Rao N R, Pandy N. Antihyperlipidemic potential of Cedrus deodara extracts in monosodium glutamate induced obesity in neonatal rats. Indian J Pharmacol [serial online] 2011 [cited 2013 May 20];43:644-7. Available from: http://www.ijp-online.com/text.asp?2011/43/6/644/89818
| » Introduction|| |
Obesity is a worldwide epidemic characterized by excess adipose tissue that contributes to numerous chronic diseases and early mortality. , Monosodium glutamate (MSG) treatment of neonatal rats produces various endocrine and behavioral abnormalities resulting from neurotoxicity to the arcuate nucleus in the hypothalamus.  MSG-treated rats develop obesity without hyperphagia as adults. 
Cedrus deodara (Roxb) Loud (Syn: Pinus deodara Roxb), a tree belongs to the Family Pinaceae.  The C. deodara are reported to have wide range of activity such as hypoglycaemic,  anticancer,  immunomodulatory,  antiinflamatory,  antioxidant.  An extensive literature survey from all scientific sources revealed that no work has been done on the anti-obese effect of the
C. deodara. Hence, the present study is undertaken to investigate the anti-obese activity of the C. deodara.
| » Materials and Methods|| |
Collection and Authentication of Plant Material
C. deodara wood was collected from Amrut Kesari Depot, Mamulpeth Bangalore, Karnataka, and was authenticated by Dr. Jawahar Raveendran, Foundation for Revitalisation of Local Health Traditions, Bangalore, Karnataka. The voucher specimen of the plant material has been deposited in the Department of Pharmacology for further reference.
Preparation of Extract
The wood of C. deodara was isolated, chopped into small pieces, dried in the shade at room temperature, and powdered. The powder was defatted with petroleum ether and then extracted with 70% v/v ethanol and acetone for 24 h in a Soxhlet extractor. After extraction, solution obtained was evaporated at 45°C under reduced pressure till a viscous mass material was obtained. The yield of the ethanolic extract (EE) and acetone extract (AE) were found to be 33.45 and 28.76 (w/w), respectively. The dried EE and AE was stored in an airtight container and placed in a refrigerator. The EE and AE were used for the experimental study.
Phytochemical analysis of the extracts
preliminary phytochemical screening was carried out on the EE and AE of the C. deodara for qualitative identification by the standard method described by Khandelwal. 
Female Albino Wistar rats (150-200 g) were purchased from the Central Animal House, Indian Institute of Science, Bangalore, Karnataka. Animals were bred in specific-pathogen-free conditions at the Central Animal House, Indian Institute of Science, where mentioned under controlled standard animal house conditions with ad libitum access to food and water. They were fed with standard rat feed (Amrut rat feed, Pranav agro industries Ltd, Sangli, India). The experiments were performed according to the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPSEA) norms after obtaining the approval of the Institutional Animal Ethics Committee (Protocol No: Ph.cology/ 11/2009-10).
Acute Toxicity Study
Acute toxicity study of EE and AE of the C. deodara was carried out by adapting fixed dose method of CPCSEA, (OECD) guidelines no 401.  The female Swiss albino mice weighing between 20-25 g were used for the study. The animals were continuously observed 12 h to detect changes in autonomic or behavioral responses. Mortality was observed for 24 hours.
Induction of MSG-induced obesity
Newborn neonatal (on the day of delivery), pups were used and injected 2 mg/g i.p. of MSG on the 2 nd and 4 th postnatal days and 4 mg/g on 6 th , 8 th , and 10 th postnatal days. Control rats received 10% NaCl (n = 08). The injection volume was 8 μl/g body weights. The Pups remained with their respective mothers until they were weaned at 4 weeks of age. At the age of 65 days, the rats' body weight was 80-100 g, rats were divided into different subgroups and later the treatment was given for 60 days orally for every day.  Group I: Vehicle control, Group II: MSG control, Group III: EE of C. deodara 100 mg/kg, Group IV: EE of C. deodara 200 mg/kg, Group V: AE of C. deodara 100 mg/kg, Group VI: AE of C. deodara 200 mg/kg.
The body weight and locomotor activity was recorded on 60 th day in vehicle control MSG control and treated group. The locomotor activity (horizontal activity) was recorded using an actophotometer. The movement of the animal cuts off a beam of light falling on the photocell and a count was recorded and displayed digitally. Each rat was placed individually in the actophotometer for 10 min and basal activity score was obtained. The vehicle control, MSG control and extracts treated rats were placed in the actophotometer for recording the activity score as described earlier.  The body temperature was recorded on day 59 in, MSG obese rats using rectal telethermometer before and after extracts administration at 0, 30, 60, 90, 120 and 180 min time interval with a contact time of 1 min. On day 61, vehicle control, MSG control and treated rats were sacrificed by ether anesthesia and then organs like heart, spleen, liver, and kidney were removed rinsed with cold saline patted between papers and weighed.
On day 61, blood was withdrawn from retroorbital sinus under ether inhalation anaesthesia and was subjected to centrifugation to obtain serum for estimating serum lipid profile. Glucose, total cholesterol, triglyceride, high density lipoprotein (HDL), low density lipoprotein (LDL), and very low density lipoprotein (VLDL) levels were measured from serum sample by using the biochemical kits (Span diagnostic Ltd, Mumbai, India).
Statistical analysis was carried out using Graph Pad Prism version 3.0 (GraphPad Software Inc., San Diego, California, USA). Data were expressed as mean ± SD (n=6) and was analyzed using one-way ANOVA followed by Dunnets test. P ≤ 0.05 was considered to be statistically significant.
| » Results|| |
Preliminary phytochemical screening revealed that EE showed positive for carbohydrates, alkaloids, saponins, fixed oil, flavonoids, and tannins. The AE showed positive for the presence of glycosides, alkaloids, triterpenoids, saponins, and flavonoids. The acute toxicity studies of the EE and AE of C. deodara was found to be non-lethal up to dose of 300 mg/kg body weight, but toxic symptoms occurs at dose at 2000 mg/kg, so the randomly 100 and 200 mg/kg doses were selected for anti-obese screening.
MSG induced obese rats showed increased in body weight and decreased the body temperature when compared to vehicle control group. Rats treated with EE and AE (200 mg/kg) showed a decrease in body weight and percentage of reduction in body weight (6.54% and 6.73%) when compared to MSG control are presented in [Table 1]. EE an AE of C. deodara (200 mg/kg) caused significantly increased the body temperature in treated group. MSG control rats' significantly decreased locomotor activity when compared to vehicle control. Administration of EE and AE (100 and 200 mg/kg) caused significantly increased locomotor activity when compared to MSG control group [Table 1]. Administration of C. deodara extracts at a dose of 200 mg/kg caused significantly reduction heart, liver, spleen, and kidney weights [Table 2].
|Table 1: Effect of ethanolic and acetone extract of Cedrus deodara wood on average body weight, locomotor activity and body temperature in neonatal monosodium glutamate inducedese rats|
Click here to view
|Table 2: Effect of ethanolic and acetone extract of Cedrus deodara wood on organ weight in neonatal monosodium glutamate induced obese rats|
Click here to view
Compared to vehicle control group, serum glucose, total cholesterol and triglyceride, LDL, and VLDL levels increased significantly in MSG control rats (P<0.01), where HDL level has been significantly (P<0.01) reduced in these group. These observations indicate that MSG increases the lipid levels in experimental obese models. Treated group with EE and AE of C. deodara decreased serum glucose, total cholesterol and triglyceride, LDL and VLDL levels, and increased HDL significantly has compared to MSG control rats. The results are showed in [Figure 1] and [Figure 2].
|Figure 1: Effect of ethanolic and acetone extract of Cedrus deodara on lipid profi le in neonatal monosodium glutamate induced obese. The results are expressed mean ± SD (n = 6). *P<0.05, **P<0.01, as|
compared to MSG control group.
Click here to view
|Figure 2: Effect of ethanolic and acetone extract of Cedrus deodara on lipid profi le in neonatal monosodium glutamate induced obese. The results are expressed mean ± SD (n = 6). *P<0.05, **P<0.01, as|
compared to MSG control group.
Click here to view
| » Discussion|| |
It is well known that the subcutaneously administration of MSG in newborn rodent produces adiposity when the animals reach adulthood. MSG obese animal resemble genetically obese animal in their greatly increased body lipid content, greatly decreased rates of hormone-stimulated lipolysis, and similar states of transient hyperglycemia.
The present study demonstrated that the anti-obese activity of C. deodara with respect to response to neonatal MSG treatment, although the degree of obesity was developed at 65 days of age. First, MSG developed obesity; increase in body weight and decrease in locomotor and body temperature (°C) was attenuated in MSG control. Food restriction reduced body weight more in treated group than in MSG control and extract treatment abolished an accelerated reduction of locomotor activity and body temperature. Secondly, increase the weight of heart, liver, spleen, kidney in MSG control. Thirdly, hypertriglyceridemia, hypercholesteromia, and hyperglycemia were enhanced in MSG-control as compared with vehicle control rats throughout the experimental period.
Neonatal MSG treatment almost completely destroys neuronal cell bodies in the arcuate nucleus of the hypothalamus  and MSG-treated rats display a characteristic syndrome of obesity, blindness, stunted growth, hypogonadism, and short tail.  The occurrence of hypertriglyceridemia, hypercholestromia was probably due to the increased hepatic VLDL synthesis induced by hyperinsulinemia. Olney  and Bunyan et al,  found that MSG treated mice were rather hypophagic and weighed less than the controls before the development of marked obesity. MSG treatment is likely suppressed energy expenditure due to the altered hypothalamic-pituitary axis contributes to MSG induced obesity. In a study by Moss et al,  thermoregulatory thermogenesis was impaired in MSG-treated mice. It has been reported that blood flow in interscapular brown adipose tissue (BAT) is a major site for energy expenditure and thermogenesis. 
The efficacy of new obesity treatments should be assessed by their effects on body weight. As such, a treatment should be considered successful if it prevents further weight gain induces a 5-10% weight loss from the initial body weight and allows long-term maintenance of the weight loss once it is achieved. The present investigation shows that extracts of C. deodara showed reduction in body weight in treated groups in a dose dependent manner.
The major chemical constituents of C. deodara are sterols, poly-phenols, flavanoids such as taxifolin, quercetin and saponins. , It is well established that saponins are useful in treatment of obesity  phytosterols have beneficial effects on hyperlipidemia  and poly-phenols and flavanoids have potential antioxidant properties. Therefore, it could be possible that presence of these compounds is responsible for observed glucose and lipid lowering activity. , Treatment with both extracts of C. deodara caused significant decrease in weights of different internal organs in MSG induced obese rats; it suggested that C. deodara reduce adipose tissue formation in rats. 
| » Conclusion|| |
In conclusion, the present study suggests that EE and AE of C. deodara showed significant antihyperlipidemic effect and it possess an anti-obesity activity against MSG induced obese rats.
| » Acknowledgements|| |
We thank Mr. Premnath Reddy, Chairman, and Dr. Divakar Goli, Principal, for providing the facilities to carry out this work.
| » References|| |
|1.||Kushner RF. Body weight and mortality. Nutr Rev 1993;5:1-10. |
|2.||Simopoulous AP, Van Ittallie TB. Body weight, health, and longevity. Ann Intern Med 1984;100:285-95. |
|3.||Olney JW Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969;164:719-21. |
|4.||Bunyan J, Murrell EA, Shah PP: The induction of obesity in rodents by means of monosodium glutamate. Br J Nutr 1976;35:25-39. |
|5.||Dev S. A selection of Prime Ayurvedic Plant Drugs Ancient-Modern Concordance, New Delhi: Anamaya Publishers; 2006. p. 119-22. |
|6.||Shivanand P, Viral D, Manish G, Subhash V, Jaganathan K. Formulate and evaluate the ethanolic extract of Cedrus deodara into capsule formulation along with its physicochemical characterization and screening for the antidiabetic activity. Int J Chem Tech Res 2009;1:1145-52. |
|7.||Singh SK, Shanmugavel M, Kampasi H, Singh R, Mondhe DM, Rao JM, et al. Cedrus deodara stem having anticancer activity. Planta Med 2007;73:519-26. |
|8.||Shinde UA. Phadke AS, Nair AM, Mungantiwar AA, Dikshit VJ, Saraf MN. Preliminary studies on the immunomodulatory activity of Cedrus deodara oil. Fitoterapia 1999;70:333-9. |
|9.||Shinde UA, Phadke AS, Nair AM, Mungantiwar AA, Dikshit VJ, Saraf MN. Studies on the anti-inflammatory and analgesic activity of Cedrus deodara. J Ethnopharmcol 1999;65:21-7. |
|10.||Tiwari AK, Srinivas PV, Kumar SP, Rao JM. Heart of Cedrus deodara shows free radical scavenging (antioxidant) activity. J Agric Food Chem 2001;49:4642. |
|11.||Khandelwal KR. Practical Pharmacognosy Techniques and Experiments Pune India: Nirali Prakashan, 2000; 149-54. |
|12.||Organization for Economic cooperation and development (OECD). OECD Guidelines for testing of chemicals Acute Oral Toxicity. Paris, France: OECD; 1993. p. 401. |
|13.||Alarcon-Aguilar FJ, Zamilpa A, Perez-Garcia MD, Almanza-Perez JC, Romero-Nunez E, Campos-Sepulveda EA, et al. Effect of Hibiscuss sabdariffa on obesity in MSG mice. J Ethnopharmacol 2007;114:66-71. |
|14.||Turner RA. Depressants of the Central Nervous System. In: Screening procedure in pharmacology. New York: Academic press; 1972. p.78. |
|15.||Meister B, Ceccatelli S, Hokfelt T, Anden NE, Anden M, Theodorsson E Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions. Exp Brain Res 1989;76:343-68. |
|16.||Moss D, Ma A, Cameron DP: Defective thermoregulatory thermogenesis in monosodium glutamate-induced obesity in mice. Metabolism 1985;34:626-30. |
|17.||Himms-Hagen J. Brown adipose tissue thermogenesis: Interdisciplinary studies. FASEB J 1990;4:2890-8. |
|18.||Agarwal PK, Agarwal SK, Rastogi RP. A new neolignan and other phenolic constituents from Cedrus deodara. Phytochemistry 1980;19:1260-1. |
|19.||George Francis, Zohar Kerem, Harinder P. S. Makkar, Klaus Becker. The biological action of saponin in animal systems: A review. Brit J Nutr 2002;88:587-605. |
|20.||David JA, Cyril WC. Plant sterols, health claims and strategies to reduce cardiovascular disease risk. J Am Coll Nutr 1999;18:559-62. |
|21.||Scalbert A, Johnson IT, Saltmorsh M. Polyphenols: antioxidents and beyond. Am J Clin Nutr 2005;81:215-7. |
|22.||Barry H, Joseph R, Andrew J. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: Direct or indirect effects? Antioxidant or not? Am J Clin Nutr 2006;81:268. |
|23.||Claudia L, Bartness TJ. Food deprivation-induced changes in body fat mobilization after neonatal monosodium glutamate treatment. Am J Physiol Regul Integr Comp Physiol 2008;294:775-83. |
[Figure 1], [Figure 2]
[Table 1], [Table 2]